Genzyme announces new malaria collaboration

Genzyme Corp., a Cambridge biotechnology company, announced today that is part of a new collaboration that seeks new treatments for malaria.

Genzyme and Medicines for Malaria Venture, or MMV, a not-for-profit virtual research and development organization, announced a new collaboration with India's Advinus Therapeutics Ltd.

"The collaboration seeks to develop new, improved treatments for specific patient groups most at risk for malaria, an often fatal infectious disease of developing countries, particularly affecting pregnant women and infants," the two said in a press release.
(By Chris Reidy, Globe staff)